
AbstractVascular endothelial growth factor (VEGF) is considered the master regulator of angiogenesis during growth and development, as well as in disease states such as cancer, diabetes, and macular degeneration. This review details our current understanding of VEGF signaling and discusses the benefits and unexpected side effects of promising anti‐angiogenic therapeutics that are currently being used to inhibit neovacularization in tumors. © 2009 International Union of Biochemistry and Molecular Biology, Inc.
Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-1, Neovascularization, Pathologic, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Receptor-2, Receptors, Vascular Endothelial Growth Factor, Neoplasms, Animals, Humans, Signal Transduction
Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-1, Neovascularization, Pathologic, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Receptor-2, Receptors, Vascular Endothelial Growth Factor, Neoplasms, Animals, Humans, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 86 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
